- Home
- CFR vs KRYS Comparison
CFR vs KRYS Comparison
Compare CFR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFR | KRYS |
|---|---|---|
| Founded | 1868 | 2015 |
| Country | United States | United States |
| Employees | 6008 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 9.6B |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CFR | KRYS |
|---|---|---|
| Price | $157.51 | $312.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 12 |
| Target Price | $172.71 | ★ $395.44 |
| AVG Volume (30 Days) | ★ 356.0K | 241.9K |
| Earning Date | 10-29-2026 | 11-02-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | 11.84 | ★ 128.00 |
| EPS | ★ 5.35 | 3.62 |
| Revenue | ★ $2,235,244,000.00 | $389,130,000.00 |
| Revenue This Year | $3.89 | $28.02 |
| Revenue Next Year | $6.60 | $28.14 |
| P/E Ratio | ★ $29.41 | $88.32 |
| Revenue Growth | 8.31 | ★ 33.94 |
| 52 Week Low | $119.15 | $183.26 |
| 52 Week High | $170.80 | $382.54 |
Technical Indicators
Market Signals| Indicator | CFR | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 38.06 |
| Support Level | $152.19 | $250.34 |
| Resistance Level | $165.28 | $317.53 |
| Average True Range (ATR) | 3.05 | 10.35 |
| MACD | 0.92 | -0.73 |
| Stochastic Oscillator | 93.23 | 6.13 |
Price Performance
Historical ComparisonAbout CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $54 billion in assets (as of June 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.